Open AccessThe effectiveness of anti-interleukin-1 therapy on subclinical inflammation parametersduring the attack-free period in familial Mediterranean fever patients: A case-control study
Author(s) -
EBRU ATALAR,
İSMAİL DOĞAN,
KEVSER GÖK,
Serdar Can Güven,
YÜKSEL MARAŞ,
GÜLAY GÜLEÇ CEYLAN,
ŞÜKRAN ERTEN
Publication year - 2022
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.55730/1300-0144.5338
Subject(s) - medicine , subclinical infection , familial mediterranean fever , inflammation , interleukin , pediatrics , immunology , disease , cytokine
: Anti IL-1 therapy is useful in suppressing attacks in FMF patients with colchicine resistance, however, it is not certain whether subclinical inflammation can sufficiently be inhibited with anti-IL-1 therapy in FMF patients with amyloidosis.